Lumibird's first quarter revenue edges up as defence boom offsets medical slump

Lumibird SA

27/04/2026 17:31

Corrects day in the first paragraph to Monday from Wednesday

April 27 (Reuters) - French laser maker Lumibird LBIRD.PA on Monday posted a 0.7% rise in its first quarter revenue to 49.7 million euros ($58.3 million) boosted by surging defence and space demand, though a weak medical performance tempered the result.

The company designs and manufactures laser systems for defence, space and industrial markets, as well as laser-based medical devices used in ophthalmology and cardiovascular treatment.

The company's defence and space business quarterly revenue jumped 21.6% to 12.8 million euros, driven by the roll-out of multi-year contracts and order book delivery

The company said medical revenue, its largest segment, fell 9.2% to 23.2 million euros, hurt by supply chain disruptions and delays induced by geopolitical tensions

Lumibird confirmed its full-year outlook

"The medical division anticipates a return to growth in the first half of the year, with an expected acceleration in the second half," CEO Marc Le Flohic said in a press release

Stripping out the impact of M&A and currency movements, total revenue grew 4.1% compared with a 0.7% rise on a reported basis

($1 = 0.8523 euros)

 (Reporting by Hugo Lhomedet; Editing by Matt Scuffham)

 ((hugo.lhomedet@thomsonreuters.com))